Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE Multivariate analysis was performed, and hazard ratios (HR) calculated for variables including female gender, 3' APC mutation, surgical intervention for FAP (colectomy with ileo-rectal anastomosis or restorative proctocolectomy), age at surgery and family history (FH) of desmoids. 20352275 2010
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GenomicAlterations disease CGI
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma. 15793634 2005
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE There is an increased risk for desmoid tumors in individuals with APC mutations between codons 543-713 and 1310-2011 when compared to a reference population. 26179480 2015
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE This family report shows that a molecular analysis of the APC gene should be performed in familial desmoid tumors for accurate genetic counseling and follow-up. 17426470 2007
Entrez Id: 324
Gene Symbol: APC
APC
0.800 Biomarker disease BEFREE The truncated APC gene retained 3 repeats in 88% (7/8) of FAP duodenal tumors, 100% (26/26) of gastric tumors retained 2 or 3 repeats and 83% (5/6) of desmoid tumors retained 2 repeats. 18224684 2008
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence. 18704758 2009
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE We performed IHC of β-catenin and mutation analysis of CTNNB1 and APC in 18 paediatric desmoid tumours, diagnosed between 1990 and 2009 in the Erasmus MC, Rotterdam. 22305464 2012
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease LHGDN Sporadic desmoid tumor in an Ashkenazi patient homozygous for the APC*I1307K gene mutation. 18770064 2008
Entrez Id: 324
Gene Symbol: APC
APC
0.800 Biomarker disease CTD_human It has been shown in molecular genetic examinations, that different mutations of the APC gene are responsible for desmoid tumors in FAP. 11816139 2001
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE The spectrum of beta-catenin and APC alterations is similar to that described for desmoid tumors of the abdomen, paraspinal region, and extremities. 11823972 2002
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. 21904137 2011
Entrez Id: 324
Gene Symbol: APC
APC
0.800 Biomarker disease HPO
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. 10782927 2000
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE Aggressive fibromatosis (AF) is a rare fibroblastic proliferative disease with a locally aggressive behavior and no distant metastasis, characterized by driver mutations in CTNNB1 or the APC gene. 25174682 2014
Entrez Id: 324
Gene Symbol: APC
APC
0.800 CausalMutation disease CLINVAR
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease LHGDN Desmoid tumors occurring in the background of familial adenomatous polyposis (FAP) usually contain inactivating germline mutations in the adenomatous polyposis coli (APC) gene. 17952864 2008
Entrez Id: 324
Gene Symbol: APC
APC
0.800 GeneticVariation disease BEFREE Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. 8221638 1993
Entrez Id: 367
Gene Symbol: AR
AR
0.020 Biomarker disease BEFREE Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation. 9060600 1997
Entrez Id: 367
Gene Symbol: AR
AR
0.020 AlteredExpression disease BEFREE Transforming growth factor-β receptor type 1 and androgen receptor were expressed in both desmoid tumors and scar, but not in fibrous tissue. 23035734 2012
Entrez Id: 407
Gene Symbol: ARR3
ARR3
0.010 AlteredExpression disease BEFREE CAR mRNA was expressed at high levels in osteosarcoma, Ewing's sarcoma, neurofibroma, and schwannoma; at intermediate levels in exostosis, giant cell tumor, liposarcoma, synovial sarcoma, malignant peripheral nerve sheath tumor, and hemangioma; and at low levels in alveolar soft part sarcoma and desmoid. 15173092 2004
Entrez Id: 8313
Gene Symbol: AXIN2
AXIN2
0.010 AlteredExpression disease BEFREE Differentially expressed transcripts (89 clones displaying increased expression in DTs and 246 clones displaying increased expression in NF) included genes encoding several receptor and non-receptor tyrosine kinases (EPHB3, PTPRF, GNAZ, SYK, LYN, EPHA4, BIRC3), transcription factors (TWIST1, PITX2, EYA2, OAS1, MITF, TCF20), and members of the Wnt signalling pathway (AXIN2, WISP1, SFRP). 16440290 2006
Entrez Id: 25805
Gene Symbol: BAMBI
BAMBI
0.010 AlteredExpression disease BEFREE A rare case of desmoid-type fibromatosis with focal metaplastic bone in the chest wall suggested that enhanced responsiveness to BMP signaling by decreasing BAMBI expression through promoter hypermethylation plays a crucial role in the formation of metaplastic bone. 16007344 2005
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.010 AlteredExpression disease BEFREE There was an increasing trend in the proportion of abnormal expression of Ki-67, Bcl-2, pRB, and p53 with the increase of tumor aggressiveness from desmoid tumors to LG-FS to HG-FS. 11306504 2001
Entrez Id: 604
Gene Symbol: BCL6
BCL6
0.010 Biomarker disease BEFREE Immunohistochemistry for BCL-6 was performed on 64 mesenchymal tumors [26 SFT (19 benign/uncertain, 7 malignant), 6 synovial sarcomas (SS), 5 gastrointestinal stromal tumors (GIST), 5 malignant peripheral nerve sheath tumors (MPNST), 5 leiomyosarcomas (LMS), 9 leiomyomas (LM) 4 desmoid tumors (DT), 4 perineuriomas (PN)]. 21725042 2011